Details for New Drug Application (NDA): 018774
✉ Email this page to a colleague
NDA 018774 describes NITROL, which is a drug marketed by Rorer and Pohl Boskamp and is included in two NDAs. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the NITROL profile page.
The generic ingredient in NITROL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
The generic ingredient in NITROL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 018774
| Tradename: | NITROL |
| Applicant: | Rorer |
| Ingredient: | nitroglycerin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018774
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.8MG/ML | ||||
| Approval Date: | Jan 19, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
